Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

New Debt Facility

21st Jun 2011 16:44

RNS Number : 8533I
Amphion Innovations PLC
21 June 2011
 



Amphion Innovations plcNew Debt Facility

London and New York, 21 June 2011- Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces it has secured additional unsecured loan financing of $2,000,000 from R. James Macaleer, Chairman of Amphion, who is also interested in 17.12% of the issued share capital of the Company. The loan is repayable on 31 December 2012 and carries interest at 5 per cent per annum. Should Amphion's licensing program achieve gross revenues of $10,000,000 during the term of the promissory note, the holder will receive interest of an additional 20 per cent per annum, payable at maturity.

This transaction is deemed a related party transaction for the purposes of the AIM Rules. As a result, the Independent Directors consider, having consulted with the Company's nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.

For further information please contact:

Amphion Innovations

Charlie Morgan

+1 212 210 6224

 

Cardew Group

Tim Robertson

+44 (0)20 7930 0777

 

Seymour Pierce Limited, Nominated Advisor

Freddy Crossley/ Mark Percy

+44 (0)20 7107 8000

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.

On the web: www.amphionplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDLCXDBGBB

Related Shares:

AMP.L
FTSE 100 Latest
Value8,275.66
Change0.00